Leukemia, Acute Myelogenous
2 clinical trials · Condition
◉ Watch Leukemia, Acute Myelogenous
| Record | Firm | Date |
|---|---|---|
| Phase I Study of Mitoxantrone and Etoposide Combined With Hydroxychloroquine, for Relapsed Acute Myelogenous Leukemia (NCT02631252) | Alison Sehgal, MD, MS | 2016-08-18 |
| Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia (NCT02665065) | Actinium Pharmaceuticals | 2016-06-01 |
Track Leukemia, Acute Myelogenous automatically
Every clearance here is in the API, with alerts when new ones post.